1. Home
  2. NTRA vs KB Comparison

NTRA vs KB Comparison

Compare NTRA & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • KB
  • Stock Information
  • Founded
  • NTRA 2003
  • KB 2008
  • Country
  • NTRA United States
  • KB South Korea
  • Employees
  • NTRA N/A
  • KB N/A
  • Industry
  • NTRA Medical Specialities
  • KB Commercial Banks
  • Sector
  • NTRA Health Care
  • KB Finance
  • Exchange
  • NTRA Nasdaq
  • KB Nasdaq
  • Market Cap
  • NTRA 24.9B
  • KB 28.6B
  • IPO Year
  • NTRA 2015
  • KB N/A
  • Fundamental
  • Price
  • NTRA $192.81
  • KB $81.42
  • Analyst Decision
  • NTRA Strong Buy
  • KB
  • Analyst Count
  • NTRA 17
  • KB 0
  • Target Price
  • NTRA $196.24
  • KB N/A
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • KB 105.9K
  • Earning Date
  • NTRA 11-07-2025
  • KB 10-23-2025
  • Dividend Yield
  • NTRA N/A
  • KB 2.42%
  • EPS Growth
  • NTRA N/A
  • KB 37.07
  • EPS
  • NTRA N/A
  • KB 10.86
  • Revenue
  • NTRA $1,964,250,000.00
  • KB $11,023,622,707.00
  • Revenue This Year
  • NTRA $24.17
  • KB $13.83
  • Revenue Next Year
  • NTRA $15.57
  • KB $1.93
  • P/E Ratio
  • NTRA N/A
  • KB $7.21
  • Revenue Growth
  • NTRA 44.38
  • KB 10.10
  • 52 Week Low
  • NTRA $119.29
  • KB $46.38
  • 52 Week High
  • NTRA $198.99
  • KB $92.39
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 68.54
  • KB 50.14
  • Support Level
  • NTRA $183.88
  • KB $80.51
  • Resistance Level
  • NTRA $198.99
  • KB $82.45
  • Average True Range (ATR)
  • NTRA 6.55
  • KB 1.61
  • MACD
  • NTRA 1.09
  • KB 0.10
  • Stochastic Oscillator
  • NTRA 80.07
  • KB 67.98

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

Share on Social Networks: